Genoset Packages

The 3.7% or so of all individuals who are both rs965513(A;A) and rs944289(T;T) are reported to be at ~5.7x increased risk for thyroid cancer compared to noncarriers

Determines if a genome has an increased risk of baldness (gs122).

Determines if a genome has an increased risk of basal cell carcinoma as per gs123.

Determines if a genome has an increased risk of basal cell carcinoma as per gs126.

Of the 'poor metabolizer' phenotype for CYP2C19.

You are a CYP2C9 poor metabolizer.

Problem metabolizing NSAIDs

Problem metabolizing ethanol with ADH (Alcohol dehydrogenase)

Determine if you have two copies of the ApoE-ε4 allele

Increased risk of gluten intolerance and celiac disease in europeans

Determines if affected by sickle cell anemia

This genoset is to be used with DNA-JSON. See the [dna2json](https://github.com/genomejs/dna2json) repository for more information.

Determines lower heart attack risk than average - 10-20% of people

Determines if a genome is 80% likely to be unable to taste bitter. (GS116)

People without this are more likely to experience lactose intolerance.

Determines if a genome has an increased risk of Alzheimer's disease. (GS293)

predicts type-1 diabetes

You have a 6.5x increased risk for breast cancer

Most likely CYP2C19 normal, i.e. CYP2C19*1, and therefore of the 'rapid metabolizer' phenotype.

Your CYP1A2 fast metabolizer status means that you are less stimulated by caffeine.